Emerging Infectious Diseases (Feb 2004)

Real-Time Reverse Transcription–Polymerase Chain Reaction Assay for SARS-associated Coronavirus

  • Shannon L. Emery,
  • Dean D. Erdman,
  • Michael D. Bowen,
  • Bruce R. Newton,
  • Jonas M. Winchell,
  • Richard F. Meyer,
  • Suxiang Tong,
  • Byron T. Cook,
  • Brian P. Holloway,
  • Karen A. McCaustland,
  • Paul A. Rota,
  • Bettina Bankamp,
  • Luis E. Lowe,
  • Tom G. Ksiazek,
  • William J. Bellini,
  • Larry J. Anderson

DOI
https://doi.org/10.3201/eid1002.030759
Journal volume & issue
Vol. 10, no. 2
pp. 311 – 316

Abstract

Read online

A real-time reverse transcription–polymerase chain reaction (RT-PCR) assay was developed to rapidly detect the severe acute respiratory syndrome–associated coronavirus (SARS-CoV). The assay, based on multiple primer and probe sets located in different regions of the SARS-CoV genome, could discriminate SARS-CoV from other human and animal coronaviruses with a potential detection limit of <10 genomic copies per reaction. The real-time RT-PCR assay was more sensitive than a conventional RT-PCR assay or culture isolation and proved suitable to detect SARS-CoV in clinical specimens. Application of this assay will aid in diagnosing SARS-CoV infection.

Keywords